| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,012 | 1,297 | 534 | 971 | | Cost of Revenue | 927 | 1,177 | 587 | 2,297 | | | Gross Profit | 85 | 120 | (53) | (1,326) | | | Operating Expenses | | Research Development | 69 | 71 | 43 | 71 | | Selling General and Administrative | 897 | 774 | 638 | 1,390 | | Non Recurring |
-
|
-
|
-
| 1,451 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (882) | (725) | (734) | (4,238) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,837 | (57) | (103) | 194 | | Earnings Before Interest And Taxes | 4,955 | (782) | (837) | (4,044) | | Interest Expense | 1,384 | 527 | 10,069 | 560 | | Income Before Tax | 3,571 | (1,309) | (10,906) | (4,605) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,092 | (1,309) | (10,906) | (4,605) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,571 | (1,309) | (10,906) | (4,605) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,571 | ($1,309) | ($10,906) | ($4,605) |
|
0.11% Nasdaq 0.00%
Income Statement
